Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.

Slides:



Advertisements
Similar presentations
Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.
Advertisements

TLR Funnel plot (according to outcomes) for studies included in the meta-analysis Death A TVR B MACE DC SE(log OR)
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical restenosis after coronary stenting: perspectives.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Clinical Results Following Stenting of.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.
Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at The American College.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.
Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
From: Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effectiveness of In-Laboratory High-Dose Clopidogrel.
Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions  Pranav Puri, Jennifer Carroll,
Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT.
Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting 
Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.
Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention  Mehmet.
American Heart Journal
Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.
The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.
Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and.
Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial.
NORSTENT Trial design: Patients with obstructive coronary artery disease were randomized to a drug-eluting stent (DES) (n = 4,504) versus a bare-metal.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Volume 54, Issue 1, Pages (August 2009)
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease  Ralf.
Volume 138, Issue 3, Pages (September 2010)
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.
Volume 55, Issue 3, Pages (May 2010)
Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation.
Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the.
Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.
Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) 
Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.
Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 
Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction.
Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.
Stenting of Coronary Arteries in Non Stress/Benestent Disease
Circ Cardiovasc Interv
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,
Electrocardiographic Diagnosis of Right Ventricular Infarction by Proximal Occlusion of a Very Dominant Right Coronary Artery  Javier García-Niebla, RN,
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Giuseppe Biondi Zoccai
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease  Ralf.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
The American College of Cardiology Presented by Dr. Maurits T. Dirksen
Standardizing definitions for hybrid coronary revascularization
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
C-reactive protein and coronary events following percutaneous coronary angioplasty  Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen,
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results  Alfredo Rodriguez,
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
The American College of Cardiology Presented by Dr. Raimund Erbel
Why surgery won the SYNTAX trial and why it matters
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Infrainguinal angioplasty with drug-eluting stents and balloons
Presented at TCT 2006.
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
M. N. Vicenzi, T. Meislitzer, B. Heitzinger, M. Halaj, L. A
Presentation transcript:

Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent Type in Patients With ST-Segment Elevation Myocardial Infarction Randomized to Bare Metal or Drug-Eluting Stenting During Primary Percutaneous Coronary Intervention  Mikkel Malby Schoos, MD, Henning Kelbæk, MD, DMSc, Klaus F. Kofoed, MD, DMSc, PhD, Lars Køber, MD, DMSc, Lene Kløvgaard, RN, Steffen Helqvist, MD, DMSc, Thomas Engstrøm, MD, DMSc, PhD, Kari Saunamäki, MD, DMSc, Erik Jørgensen, MD, DMSc, Lene Holmvang, MD, DMSc, Peter Clemmensen, MD, DMSc  American Journal of Cardiology  Volume 107, Issue 11, Pages 1597-1603 (June 2011) DOI: 10.1016/j.amjcard.2011.01.042 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Adverse events by median high-sensitivity C-reactive protein level ≤2 mg/L (blue bars) and >2 mg/L (red bars). re-MI IRA = recurrent infarction in infarct-related artery; ST = stent thrombosis; TLR = target lesion revascularization; TVR = target vessel revascularization. American Journal of Cardiology 2011 107, 1597-1603DOI: (10.1016/j.amjcard.2011.01.042) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Adverse events by high-sensitivity C-reactive protein quartiles 1 (blue bars), 2 (red bars), 3 (green bars), and 4 (purple bars). Abbreviations as in Figure 1. American Journal of Cardiology 2011 107, 1597-1603DOI: (10.1016/j.amjcard.2011.01.042) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Adverse events according to bare metal stent plus high-sensitivity C-reactive protein level ≤2 mg/L (blue bars), drug-eluting stent plus high-sensitivity C-reactive protein level ≤2 mg/L (red bars), drug-eluting stent plus high-sensitivity C-reactive protein level >2 mg/L (green bars), and bare metal stent plus high-sensitivity C-reactive protein level >2 mg/L (purple bars) (p <0.001). Abbreviations as in Figure 1. American Journal of Cardiology 2011 107, 1597-1603DOI: (10.1016/j.amjcard.2011.01.042) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Kaplan–Meier for event-free survival (log function) demonstrated significant differences (p = 0.004) for occurrence of myocardial infarction and death, where the following order was increasingly detrimental: bare metal stent plus high-sensitivity C-reactive protein ≤2 mg/L (blue line), drug-eluting stent plus high-sensitivity C-reactive protein ≤2 mg/L (green line), drug-eluting stent plus high-sensitivity C-reactive protein >2 mg/L (yellow line), bare metal stent plus high-sensitivity C-reactive protein >2 mg/L (purple line). American Journal of Cardiology 2011 107, 1597-1603DOI: (10.1016/j.amjcard.2011.01.042) Copyright © 2011 Elsevier Inc. Terms and Conditions